Company Monitoring Page for Merck

latest headlines for company on cafepharma

Merck & Co. buying SmartCells for $500 million
Marketwatch
Thu, 12/2/10 - 09:20 am
Tags:
SmartCells, M&A, Merck, diabetes
Merck's Proscar Fails to Win U.S. FDA Panel's Backing for Prostate Cancer
Bloomberg
Wed, 12/1/10 - 05:55 pm
Tags:
Merck, Proscar, FDA, prostate cancer
Incoming Merck chief to focus on pricing
FT.com
Wed, 12/1/10 - 07:18 am
Tags:
Merck, Pharma CEOs, pricing, Kenneth Frazier
FDA disputes prostate drugs' risk-cutting power
Fierce Pharma
Tue, 11/30/10 - 10:59 am
Tags:
FDA, GSK, prostate cancer, Avodart, Merck, Proscar
Drug groups face new generics threat
FT.com
Tue, 11/30/10 - 10:57 am
Tags:
generics, Roche, Merck, JNJ, Abbott Laboratories, biogenerics
RNAi Is On Sale
Motley Fool
Tue, 11/30/10 - 10:52 am
Tags:
RNAi, Merck, Alnylam, Pfizer, Amgen, Novartis, Eli Lilly, Roche
Merck Names Kenneth Frazier CEO, Clark Stays as Chairman
Bloomberg
Tue, 11/30/10 - 09:15 am
Tags:
Merck, Pharma CEOs, Kenneth Frazier
Drug groups face new generics threat
FT.com
Mon, 11/29/10 - 02:50 pm
Tags:
generics, Roche, Merck, JNJ, Abbott Laboratories, GSK, AstraZeneca, Teva Pharmaceuticals, Hospira, Novartis
An Innovator’s Dilemma For Merck AIDS Drug
Forbes
Mon, 11/29/10 - 11:24 am
Tags:
Merck, HIV, AIDS, Isentress
Merck's Risky Bet on Heart Drugs May Yield Pills with Lipitor-Like Success
Bloomberg
Sat, 11/27/10 - 01:17 pm
Tags:
Merck, Pfizer, CETP inhibitors
Is Merck the Perfect Stock?
Motley Fool
Wed, 11/24/10 - 08:34 am
Tags:
Merck
Ariad Gets Good News on Its Endometrial Cancer Drug
Seeking Alpha
Tue, 11/23/10 - 09:27 am
Tags:
endometrial cancer, Ariad Pharmaceuticals, Merck, mTOR inhibitors, ridaforolimus
Let's Call It a Partial Victory (Merck)
Motley Fool
Tue, 11/23/10 - 08:57 am
Tags:
Merck, Vytorin, kidney disease
Genzyme ($GENZ) proffers milestone-based deal to potential suitors
Fierce Biotech
Mon, 11/22/10 - 12:43 pm
Tags:
Genzyme, milestone payments, Sanofi, M&A, Pfizer, Merck, JNJ
Merck, Vytorin & Questionable Oxford Researchers
Pharmalot
Mon, 11/22/10 - 12:39 pm
Tags:
Merck, Vytorin
Merck Wins Third Fosamax Trial; Record Now Stands at 2-1
WSJ Online
Mon, 11/22/10 - 10:41 am
Tags:
Merck, Fosamax, lawsuits
Merck Cholesterol Drug Is Found to Help Kidney Patients
WSJ Online
Mon, 11/22/10 - 10:23 am
Tags:
Merck, Vytorin, kidney disease
VYTORIN(R) (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease in a New 9,000-Patient Investigational Study
MarketWatch
Sat, 11/20/10 - 01:35 pm
Tags:
Vytorin, Merck, chronic kidney disease
Merck Wins Another Federal FOSAMAX® (alendronate sodium) Bellwether Trial
Yahoo/BusinessWire
Sat, 11/20/10 - 12:41 pm
Tags:
Merck, Fosamax, lawsuits
Merck's CETP Compound Sails Ahead Into Potentially Murky Waters
Seeking Alpha
Sat, 11/20/10 - 12:20 pm
Tags:
Merck, CETP inhibitors, Anacetrapib, cholesterol

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.